A Phase 1 Single-Dose Escalation Study of PF-04308515 in Healthy Volunteers

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Volunteers

In brief

The purpose of this study is to determine the safety, tolerability, pharmacokinetics (understanding how a drug is absorbed and moves through the body) and pharmacodynamics (understanding the effects of a drug on certain target sites of activity in the body).

Key facts

Study ID

NCT00990015

Run by

Pfizer

People needed

27

Starts

2009-10-01

Expected to finish

2010-01-01

Last updated by the study team

2010-02-01

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy males between 18 and 55 years, inclusive
• Healthy females between 18 and 44 years, inclusive.
• Women need to be surgically sterile

You may not qualify if…

• Evidence or history of clinically significant disease
• Post-menopausal women
• History of intolerance or significant adverse effects with glucocorticoids

Where it is running

• Pfizer Investigational Site — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.